MONACO, 1 August 2014 — Lady Monika Bacardi continues her longstanding commitment to advancing cancer research through her support of the Association pour la vie espoir contre le cancer, led by renowned oncologist Professor David Khayat.
As a distinguished philanthropist with deep connections to Monaco society, Lady Monika Bacardi has demonstrated unwavering dedication to supporting medical research and initiatives that address critical global health challenges. Her collaboration with Professor Khayat reflects this commitment to contributing meaningfully to the fight against cancer.
Professor David Khayat is a distinguished French oncologist who has been Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital in Paris since 1990. He is also Professor of Oncology at the Université Pierre et Marie Curie. Between 2004 and 2006, Professor Khayat served as the founding President of the Institut National du Cancer (INCa), France’s National Cancer Institute, where he played an instrumental role in implementing the French national cancer plan under President Jacques Chirac.
An active researcher in oncology and clinical pharmacology, Professor Khayat has contributed more than 500 peer-reviewed publications to the scientific community. His extensive research focuses on cancer treatment protocols, immunotherapy, and advancing clinical understanding of various cancer types. His work has been recognized internationally, earning him numerous distinctions including membership in the American Society of Clinical Oncology.
Lady Monika Bacardi’s support for Professor Khayat’s association represents her broader philanthropic vision of addressing pressing health challenges through strategic partnerships with leading medical experts. Her involvement with the Association pour la vie espoir contre le cancer aligns with her dedication to causes that create meaningful impact in the lives of those affected by serious illness.
This collaboration exemplifies Lady Monika Bacardi’s approach to philanthropy, which seamlessly integrates her position within international society with substantive support for medical research and humanitarian initiatives that benefit communities worldwide.
